Abstract:Neurodegenerative diseases (NDs) such as Alzheimer's Disease (AD) and Parkinson's Disease (PD) are devastating conditions that can develop without noticeable symptoms, causing irreversible damage to neurons before any signs become clinically evident. NDs are a major cause of disability and mortality worldwide. Currently, there are no cures or treatments to halt their progression. Therefore, the development of early detection methods is urgently needed to delay neuronal loss as soon as possible. Despite advancements in Medtech, the early diagnosis of NDs remains a challenge at the intersection of medical, IT, and regulatory fields. Thus, this review explores "digital biomarkers" (tools designed for remote neurocognitive data collection and AI analysis) as a potential solution. The review summarizes that recent studies combining AI with digital biomarkers suggest the possibility of identifying pre-symptomatic indicators of NDs. For instance, research utilizing convolutional neural networks for eye tracking has achieved significant diagnostic accuracies. ROC-AUC scores reached up to 0.88, indicating high model performance in differentiating between PD patients and healthy controls. Similarly, advancements in facial expression analysis through tools have demonstrated significant potential in detecting emotional changes in ND patients, with some models reaching an accuracy of 0.89 and a precision of 0.85. This review follows a structured approach to article selection, starting with a comprehensive database search and culminating in a rigorous quality assessment and meaning for NDs of the different methods. The process is visualized in 10 tables with 54 parameters describing different approaches and their consequences for understanding various mechanisms in ND changes. However, these methods also face challenges related to data accuracy and privacy concerns. To address these issues, this review proposes strategies that emphasize the need for rigorous validation and rapid integration into clinical practice. Such integration could transform ND diagnostics, making early detection tools more cost-effective and globally accessible. In conclusion, this review underscores the urgent need to incorporate validated digital health tools into mainstream medical practice. This integration could indicate a new era in the early diagnosis of neurodegenerative diseases, potentially altering the trajectory of these conditions for millions worldwide. Thus, by highlighting specific and statistically significant findings, this review demonstrates the current progress in this field and the potential impact of these advancements on the global management of NDs.

Parameter Uncertainty for Aircraft Aerodynamic Modeling using Recursive Least Squares

Early Diagnosis of Alzheimer's Disease Using Deep Learning

Develop a Diagnostic Tool for Dementia Using Machine Learning and Non-Imaging Features

Predictive deep learning models for cognitive risk using accessible data

Deep Learning in Alzheimer's Disease: Diagnostic Classification and Prognostic Prediction Using Neuroimaging Data

Early Diagnosis of Alzheimer's Disease Based on Resting-State Brain Networks and Deep Learning

A robust and clinically applicable deep learning model for early detection of Alzheimer's

Deep Learning-Based Diagnosis of Alzheimer’s Disease

Deep learning based computer aided diagnosis of Alzheimer's disease: a snapshot of last 5 years, gaps, and future directions

An Accurate Prediction and Diagnosis of Alzheimer’s Disease using Deep Learning

Resting State fMRI and Improved Deep Learning Algorithm for Earlier Detection of Alzheimer’s Disease

An Artificial Intelligence-Assisted Method for Dementia Detection Using Images from the Clock Drawing Test

Multimodal deep learning for Alzheimer’s disease dementia assessment

Neuroimaging and Machine Learning for Dementia Diagnosis: Recent Advancements and Future Prospects.

Multimodal deep learning models for early detection of Alzheimer’s disease stage

Dual Attention Aware Octave Convolution Network for Early-Stage Alzheimer's Disease Detection

Artificial intelligence for dementia—Applied models and digital health

Development of an AI-Based Predictive Algorithm for Early Diagnosis of High-Risk Dementia Groups among the Elderly: Utilizing Health Lifelog Data

Addressing the Gaps in Early Dementia Detection: A Path Towards Enhanced Diagnostic Models through Machine Learning

Machine Learning and Digital Biomarkers Can Detect Early Stages of Neurodegenerative Diseases

Deep learning techniques for automated Alzheimer's and mild cognitive impairment disease using EEG signals: A comprehensive review of the last decade (2013 - 2024)